Association between charcoal cooking fuel and cardiovascular disease prevalence in Haiti: a cross-sectional analysis

海地木炭烹饪燃料与心血管疾病患病率之间的关联:一项横断面分析

阅读:1

Abstract

BACKGROUND: There is little evidence on the association between cooking with polluting fuels, particularly charcoal, and heart disease from low- and middle-income countries, which have the highest burdens of polluting fuels and cardiovascular disease (CVD). We sought to assess the relationship between self-reported primary home cooking with charcoal and prevalent cardiovascular disease in the low-income country Haiti. METHODS: Demographic and clinical data were collected from 3,005 adults in the Haiti Cardiovascular Disease Cohort, recruited from Port-au-Prince using multistage random sampling from 2019 to 2021. Primary cooking fuel was self-reported in the household: charcoal orliquified petroleum gas (LPG). Prevalent CVD (heart failure, stroke, myocardial infarction) was physician-adjudicated using epidemiological criteria similar to international cohorts. Multivariable generalized estimating equations with a Poisson distribution estimated prevalence ratios of prevalent CVD by polluting charcoal vs. LPG. RESULTS: Among 2,865 adults in the analytic sample, median age was 41 years (IQR 28–55), 57.9% female, and 88.4% reported using charcoal cooking fuel. Age-adjusted prevalence of any CVD was 13.7% (95% CI 12.2%, 15.4%) with the most common subtype being heart failure. Cooking with charcoal versus LPG was associated with higher prevalence of heart failure (1.63 prevalence ratio; 95% confidence interval 1.09, 2.44) after multivariable adjustment, lower prevalence of stroke, and not significantly associated with myocardial infarction or any CVD. CONCLUSION: Most urban Haitian adults cook with charcoal, an uncommon primary cooking fuel in other countries, and charcoal is associated with higher prevalence of heart failure compared to LPG. Polluting charcoal cooking fuel is a potentially modifiable risk factor for heart failure in low-income settings that needs remediation and intervention. TRIAL REGISTRATION: Registry: clinicaltrials.gov. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12940-026-01292-w.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。